MiMedx Group Inc. (MDXG) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

MiMedx Group Inc. (MDXG)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

8.60

0.04 (0.47%)

At close: Jan 14, 2025, 3:59 PM

8.21

-4.48%

Pre-market Jan 15, 2025, 07:14 AM EST

undefined% (undefined)

Bid	8.2
Market Cap	1.26B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.57
PE Ratio (ttm)	15.08
Forward PE	n/a
Analyst	Buy

Ask	8.5
Volume	583,323
Avg. Volume (20D)	827,147
Open	8.60
Previous Close	8.56
Day's Range	8.54 - 8.66
52-Week Range	5.47 - 10.14
Beta	undefined

About MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its produc...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Feb 12, 2008

Employees 895

Stock Exchange NASDAQ

Ticker Symbol MDXG

Website https://www.mimedx.com

Analyst Forecast

According to 5 analyst ratings, the average rating for MDXG stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 33.80% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

MiMedx Group Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $87.64M, reflecting a 0.93% YoY growth and earnings per share of 0.06, making a 50.00% increase YoY.

Why Price Moved

2 months ago · Source

+23.56%

MiMedx Group shares are trading higher after the c... Unlock content with Pro Subscription

2 months ago · Source

+20.39%

MiMedx Group shares are trading higher after the company reported better-than-expected Q3 financial results.

News

4 weeks ago · zacks.com

MiMedx (MDXG) is on the Move, Here's Why the Trend Could be Sustainable

MiMedx (MDXG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho...

1 month ago · zacks.com

Recent Price Trend in MiMedx (MDXG) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, MiMedx (MDXG) could be a great choice. It is one of the several stocks that passed through our "Recent Price St...

1 month ago · zacks.com

How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%

The mean of analysts' price targets for MiMedx (MDXG) points to a 37.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts ...

2 months ago · zacks.com

MiMedx (MDXG) Is a Great Choice for 'Trend' Investors, Here's Why

2 months ago · zacks.com

Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 77.9% upside potential for MiMedx (MDXG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r...

2 months ago · seekingalpha.com

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

MiMedx Group, Inc. (NASDAQ:MDXG ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Matt Notarianni - Head, Investor Relations Joe Capper - Chief Executive Officer Doug...

2 months ago · zacks.com

MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates

MiMedx (MDXG) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.